AbbVie nears $11bn Apogee deal
AbbVie is closing in on a nearly $11 billion deal for biotech company Apogee Therapeutics
AbbVie closes in on nearly $11bn deal for biotech Apogee Therapeutics -- FT
AbbVie is closing in on a nearly $11 billion deal for biotech company Apogee Therapeutics
AbbVie closes in on nearly $11bn deal for biotech Apogee Therapeutics -- FT